Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. (Q45382355)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 July 2009

Language	Label	Description	Also known as
English	Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.	scientific article published on 31 July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Shigefumi Okamoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Masaaki Matsuura

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Takami Akagi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Mitsuru Akashi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Takeshi Tanimoto

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Toyokazu Ishikawa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Michiaki Takahashi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Koichi Yamanishi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Yasuko Mori

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

0 references

publication date

31 July 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

5896-5905

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Current status of live attenuated influenza virus vaccine in the US.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Induction of heterosubtypic immunity to influenza virus by intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.037

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.037

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647814%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45382355&oldid=1775329540"